Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals Academic Article uri icon

Overview

MeSH Major

  • Anti-HIV Agents
  • Central Nervous System Diseases
  • Mood Disorders
  • Oxazines
  • Reverse Transcriptase Inhibitors

abstract

  • In a large controlled trial, efavirenz use was associated with neurologic symptoms distinct from depression and anxiety that began early in therapy but resolved by week 4. Improvement in neuropsychological performance was comparable in patients who were receiving efavirenz and those who were not.

publication date

  • November 15, 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 16287792

Additional Document Info

start page

  • 714

end page

  • 21

volume

  • 143

number

  • 10